Aims: To study the prescriptions of clinically diagnosed cases of dermatophytoses, to evaluate medical treatment of clinical failure
cases, any rise in serum ALT (Alanine aminotransferase) levels associated with usage of oral anti-fungal drugs, availability
of drugs in the hospital pharmacy and cost minimization of different oral treatment regimens with Griseofulvin, Fluconazole,
Itraconazole and Terbinafine.
Settings and design: Dermatology Out Patient Department (OPD) of a tertiary care hospital, single centre prospective cohort
observational study.
Materials and Methods: 370 patients from the Dermatology Out Patient Department (OPD) diagnosed of dermatophytoses
were enrolled. Follow-up was done 3±1 weeks apart, twice for newly diagnosed patients and once for patients on ongoing
therapy. Two separate blood samples were collected 3±1 weeks apart for estimation of serum ALT. The prime lesion in each
patient was graded as mild, moderate and severe. Patients were categorized as clinically cured, clinically improved, or as
clinical failure following treatment.
Statistical analysis used: Descriptive statistics, Fischer’s exact test and Wilcoxon’s signed rank test.
Results: Azoles were the most commonly prescribed antifungals. Clinical status of patients was independent of the oral
antifungal drug received (p > 0.05). A statistically significant difference in clinical status between compliant and non-compliant
patients was seen (p < 0.05). A statistically significant increase in serum ALT levels was seen (p < 0.05) however, it was not
clinically significant. 55.52% of drugs were unavailable in the hospital formulary. The average expenses per prescription was
approximately INR 1123.55. Itraconazole was the most expensive treatment regimen followed by terbinafine and fluconazole.
Conclusions: There exists a non-uniformity in the management of dermatophytoses due to lack of adequate guidance and nonavailability of drugs and clinical cure of patients depends upon compliance to therapy.